A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone-induced interstitial pneumonia.
Future Cardiol
; 17(6): 991-997, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-983819
ABSTRACT
Amiodarone is a drug commonly used to treat and prevent cardiac arrhythmias, but it is often associated with several adverse effects, the most serious of which is pulmonary toxicity. A 79-year-old man presented with respiratory failure due to interstitial pneumonia during the COVID-19 pandemic. The viral etiology was nevertheless excluded by repeated nasopharyngeal swabs and serological tests and the final diagnosis was amiodarone-induced organizing pneumonia. The clinical and computed tomography findings improved after amiodarone interruption and steroid therapy. Even during a pandemic, differential diagnosis should always be considered and pulmonary toxicity has to be taken into account in any patient taking amiodarone and who has new respiratory symptoms.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Lung Diseases, Interstitial
/
Amiodarone
/
Anti-Arrhythmia Agents
Type of study:
Case report
/
Diagnostic study
/
Etiology study
/
Prognostic study
Limits:
Aged
/
Humans
/
Male
Language:
English
Journal:
Future Cardiol
Journal subject:
Cardiology
Year:
2021
Document Type:
Article
Affiliation country:
Fca-2020-0168
Similar
MEDLINE
...
LILACS
LIS